Aileron Therapeutics (ALRN) : That's a pass for me!
This is a draft that I’ve made on this company. Spoiler : It’s a bad investment. I think it’s important to also show companies that I disapprove to show what are, in my opinion, dealbreakers when investing in this sector.
What is Aileron?
Its mission is to protect the healthy cells in patients when doing chemotherapy :
We are developing ALRN-6924 as a nove…